176 related articles for article (PubMed ID: 26686579)
1. Targeting transcription factors by small compounds--Current strategies and future implications.
Hagenbuchner J; Ausserlechner MJ
Biochem Pharmacol; 2016 May; 107():1-13. PubMed ID: 26686579
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs against cancer: an evolving landscape.
Di Costanzo A; Del Gaudio N; Migliaccio A; Altucci L
Arch Toxicol; 2014 Sep; 88(9):1651-68. PubMed ID: 25085708
[TBL] [Abstract][Full Text] [Related]
3. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
[TBL] [Abstract][Full Text] [Related]
4. New drugs target hypoxia response in tumors.
Garber K
J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
[No Abstract] [Full Text] [Related]
5. Targeting Transcription Factors for Cancer Treatment.
Lambert M; Jambon S; Depauw S; David-Cordonnier MH
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921764
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor Drug Targets.
Papavassiliou KA; Papavassiliou AG
J Cell Biochem; 2016 Dec; 117(12):2693-2696. PubMed ID: 27191703
[TBL] [Abstract][Full Text] [Related]
7. A rationally designed small molecule that inhibits the HIF-1alpha-ARNT heterodimer from binding to DNA in vivo.
Vinson C
Sci STKE; 2005 May; 2005(284):pe23. PubMed ID: 15900031
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
9. Use of transcription factors as agents and targets for drug development.
Smith LM; Birrer MJ
Oncology (Williston Park); 1996 Oct; 10(10):1532-8; discussion 1541-2. PubMed ID: 8905845
[TBL] [Abstract][Full Text] [Related]
10. Finding their groove; bifunctional molecules arrest growth of cancer cells.
Mapp AK
Chem Biol; 2004 Nov; 11(11):1480-2. PubMed ID: 15555997
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors and neoplasia: vistas in novel drug design.
Karamouzis MV; Gorgoulis VG; Papavassiliou AG
Clin Cancer Res; 2002 May; 8(5):949-61. PubMed ID: 12006506
[TBL] [Abstract][Full Text] [Related]
12. Touch and go: nuclear proteolysis in the regulation of metabolic genes and cancer.
Maneix L; Catic A
FEBS Lett; 2016 Apr; 590(7):908-23. PubMed ID: 26832397
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor based therapeutics: drugs of the future?
Peterson MG; Baichwal VR
Trends Biotechnol; 1993 Jan; 11(1):11-8. PubMed ID: 7763378
[TBL] [Abstract][Full Text] [Related]
14. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
15. Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.
Sharlow ER; Wipf P; McQueeney KE; Bakan A; Lazo JS
Expert Opin Investig Drugs; 2014 May; 23(5):661-73. PubMed ID: 24625356
[TBL] [Abstract][Full Text] [Related]
16. Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression.
Bouhlel MA; Lambert M; David-Cordonnier MH
Curr Top Med Chem; 2015; 15(14):1323-58. PubMed ID: 25866275
[TBL] [Abstract][Full Text] [Related]
17. Transcription factors as targets for DNA-interacting drugs.
Gniazdowski M; Denny WA; Nelson SM; Czyz M
Curr Med Chem; 2003 Jun; 10(11):909-24. PubMed ID: 12678680
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
20. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
